Cargando…

TMED2 as a marker of prognosis in breast cancer [Letter]

Detalles Bibliográficos
Autores principales:	Schwarz, Megan Catherine, Allikmets, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636177/ https://www.ncbi.nlm.nih.gov/pubmed/31372042 http://dx.doi.org/10.2147/CMAR.S210756

Ejemplares similares

Advocating a bottom-up approach in the teaching of feedback skills to medical students [Letter]
por: Allikmets, Silvia, et al.
Publicado: (2019)

Expression of TMED3 is independently associated with colorectal cancer prognosis
por: Wang, Rong-Fei, et al.
Publicado: (2022)

The circular RNA CDR1as regulate cell proliferation via TMED2 and TMED10
por: Yang, Xue, et al.
Publicado: (2020)

Increased expression of TMED2 is an unfavorable prognostic factor in patients with breast cancer
por: Lin, Xia, et al.
Publicado: (2019)

TMED2 promotes epithelial ovarian cancer growth
por: Shi-Peng, Gong, et al.
Publicado: (2017)

Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer
por: Fang, Zheng, et al.
Publicado: (2022)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

Expression and Importance of TMED2 in Multiple Myeloma Cells
por: Ge, Xueling, et al.
Publicado: (2020)

Depths of Malignancy: On the Prognosis of Breast Cancer [Letter]
por: Zehra, Syeda Sakina, et al.
Publicado: (2023)

Unconventional secretion: cargo channeling by TMED10
por: Nguyen, Tan A., et al.
Publicado: (2020)

TMED family genes and their roles in human diseases
por: Zhou, Lv, et al.
Publicado: (2023)

TMED2 binding restricts SMO to the ER and Golgi compartments
por: Di Minin, Giulio, et al.
Publicado: (2022)

Depleting TMED3 alleviates the development of endometrial carcinoma
por: Zhang, Jin, et al.
Publicado: (2022)

The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases
por: Mishra, Sonakshi, et al.
Publicado: (2019)

Depths of Malignancy: On the Prognosis of Breast Cancer [Response to Letter]
por: He, Jing, et al.
Publicado: (2023)

TMED3 Promotes Proliferation and Migration in Breast Cancer Cells by Activating Wnt/β-Catenin Signaling
por: Zhang, Xiumei, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2
por: Hou, Wenyang, et al.
Publicado: (2017)

RAB21 interacts with TMED10 and modulates its localization and abundance
por: Del Olmo, Tomas, et al.
Publicado: (2019)

Trafficking protein TMED3 promotes esophageal squamous cell carcinoma
por: Yang, Yuxian, et al.
Publicado: (2023)

TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p
por: Pei, Jing, et al.
Publicado: (2019)

TMED3/RPS15A Axis promotes the development and progression of osteosarcoma
por: Xu, Wei, et al.
Publicado: (2021)

Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer
por: Sial, Nuzhat, et al.
Publicado: (2021)

Importance of incorporating teaching of feedback skills into medical curricula
por: Allikmets, Silvia, et al.
Publicado: (2016)

TMED3 promotes the progression and development of lung squamous cell carcinoma by regulating EZR
por: Xie, An, et al.
Publicado: (2021)

The benefits of peer-led teaching in medical education
por: Allikmets, Silvia, et al.
Publicado: (2016)

TMED10 mediates the trafficking of insulin-like growth factor 2 along the secretory pathway for myoblast differentiation
por: Li, Tiantian, et al.
Publicado: (2023)

TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling
por: Zheng, Hao, et al.
Publicado: (2016)

Knockdown of TMED3 inhibits cell viability and migration and increases apoptosis in human chordoma cells
por: Yang, Jinxing, et al.
Publicado: (2021)

The many hats of transmembrane emp24 domain protein TMED9 in secretory pathway homeostasis
por: Roberts, Benjamin S., et al.
Publicado: (2023)

TMED3 Complex Mediates ER Stress‐Associated Secretion of CFTR, Pendrin, and SARS‐CoV‐2 Spike
por: Park, Hak, et al.
Publicado: (2022)

Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma
por: Yang, Yi-Chieh, et al.
Publicado: (2021)

Prognostic Role of TMED3 in Clear Cell Renal Cell Carcinoma: A Retrospective Multi-Cohort Analysis
por: Ha, Mihyang, et al.
Publicado: (2019)

Circular RNA circ_0008305 aggravates hepatocellular carcinoma growth through binding to miR‐186 and inducing TMED2
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

Identification of a novel circ_0018289/miR-183-5p/TMED5 regulatory network in cervical cancer development
por: Zou, Heng, et al.
Publicado: (2021)

Early but Quality Diagnosis: On Breast Cancer and Its Risk Factors [Letter]
por: Zehra, Syeda Sakina, et al.
Publicado: (2023)

A new type of ERGIC–ERES membrane contact mediated by TMED9 and SEC12 is required for autophagosome biogenesis
por: Li, Shulin, et al.
Publicado: (2021)

High-Throughput Transcriptomic and RNAi Analysis Identifies AIM1, ERGIC1, TMED3 and TPX2 as Potential Drug Targets in Prostate Cancer
por: Vainio, Paula, et al.
Publicado: (2012)

2. The Letters
Publicado: (2011)

2. The Letters
Publicado: (2011)

2. The Letters
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2ma6h9n3fie17p3qpnm8c27u4s